TCT 1015: External Validation of the xDAPT Machine Learning Model for Ischemic and Bleeding Risk After Percutaneous Coronary Intervention
We Recommend
Disclosures
<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker's Bureau - Terumo Medical Corporation</li></ul>